April 23, 2020 / 6:07 PM / a month ago

BRIEF-Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

April 23 (Reuters) - Caladrius Biosciences Inc:

* CALADRIUS BIOSCIENCES ANNOUNCES $5.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

* CALADRIUS BIOSCIENCES INC - AGREEMENTS FOR ISSUANCE AND SALE OF 2.2 MILLION SHARES OF COMMON STOCK AT $2.3125 PER SHARE

* CALADRIUS BIOSCIENCES INC - INTENDS TO USE NET PROCEEDS FROM OFFERING FOR ADVANCEMENT OF ITS CD34+ TECHNOLOGY-BASED CLINICAL PROGRAMS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below